Oral capecitabine (Xeloda) in cancer treatment.
Doyle
Diane P
DP
Medical Oncology/Solid Tumor Service, Lahey Clinic, Burlington, MA, USA.
Engelking
Constance
C
D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms / Q000188:drug therapy*; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring; D005333:Fetus / Q000187:drug effects; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D024802:Nurse's Role; D010353:Patient Education as Topic; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil